EVMN

Evommune Inc. Common Stock (EVMN)

Stock · NYSE · Health Care

$13.23as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$22.47
Industry
Biotechnology: Pharmaceutical Preparations

Evommune Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • EVMN
    Evommune Inc. Common Stock
    $13.23
    ▼ 1.85%
    Market cap $417.45MP/E
  • BNTC
    Benitec Biopharma Inc. Common Stock
    $12.51
    ▼ 1.30%
    Market cap $417.41MP/E
    $9.85$16.76
  • KMDA
    Kamada Ltd. Ordinary Shares
    $8.29
    ▲ 0.36%
    Market cap $417.07MP/E 20.65
    $6.5$9.35
  • LRMR
    Larimar Therapeutics Inc. Common Stock
    $4
    ▼ 1.23%
    Market cap $413.45MP/E
    $2.72$6.42
  • PRTA
    Prothena Corporation plc Ordinary Shares
    $9.35
    ▲ 2.86%
    Market cap $436.10MP/E
    $7.73$11.8
  • EOLS
    Evolus Inc. Common Stock
    $8.89
    ▲ 0.06%
    Market cap $398.42MP/E
    $3.86$9.12
  • SGMT
    Sagimet Biosciences Inc. Series A Common Stock
    $10.55
    ▼ 1.86%
    Market cap $441.53MP/E
    $4.5$11.15

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
32.89M
Total value held
$730.28M
Institutional holders
79
Top holders this quarter
  • Unknown4.93M
  • Unknown3.49M
  • Unknown1.93M
  • Unknown1.90M
  • Unknown1.50M
  • Unknown1.46M
  • Unknown1.44M
  • Unknown1.28M
  • Unknown1.21M
  • Unknown1.12M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.